Naltrexone increases the latency to drink alcohol in social drinkers.
about
Opioid antagonists for alcohol dependencePharmacokinetics, safety, and tolerability of a depot formulation of naltrexone in alcoholics: an open-label trial.A Phase 2, Double-Blind, Placebo-Controlled Randomized Trial Assessing the Efficacy of ABT-436, a Novel V1b Receptor Antagonist, for Alcohol Dependence.Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.Ethanol consumption: how should we measure it? Achieving consilience between human and animal phenotypesA human alcohol self-administration paradigm to model individual differences in impaired control over alcohol use.A scoping review of risk behaviour interventions in young menEffects of naltrexone and nalmefene on subjective response to alcohol among non-treatment-seeking alcoholics and social drinkers.The pharmacotherapy of alcohol dependence: a state of the art review.The Effects of Naltrexone Among Alcohol Non-Abstainers: Results from the COMBINE Study.Critical thoughts on current rodent models for evaluating potential treatments of alcohol addiction and withdrawalPharmacogenetics of naltrexone in asian americans: a randomized placebo-controlled laboratory study.The long-lasting effects of JDTic, a kappa opioid receptor antagonist, on the expression of ethanol-seeking behavior and the relapse drinking of female alcohol-preferring (P) ratsNaltrexone decreases heavy drinking rates in smoking cessation treatment: an exploratory study.Pharmacological Options for Smoking Cessation in Heavy-Drinking SmokersEffect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people.Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.Effects of the opioid receptor antagonist naltrexone on smoking and related behaviors in smokers preparing to quit: a randomized controlled trialEmerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment.The role of the opioid system in alcohol dependence.Effects of naltrexone on alcohol self-administration and craving: meta-analysis of human laboratory studies.Urgency traits moderate daily relations between affect and drinking to intoxication among young adults.A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene.Prevention of alcohol dependence: strategies for selective, indicated, and universal prevention.Use of naltrexone in the treatment of alcoholism nationally in the Department of Veterans Affairs.Effects of acute tryptophan depletion on negative symptoms and smoking topography in nicotine-dependent schizophrenics and nonpsychiatric controls.The effect of naltrexone on alcohol's stimulant properties and self-administration behavior in social drinkers: influence of gender and genotype.Effects of naltrexone on alcohol self-administration in heavy drinkers.Genetic moderators of naltrexone's effects on alcohol cue reactivity.Development of naltrexone supersensitivity during food-maintained responding enhances naltrexone's ability to reduce ethanol-maintained responding.Naltrexone's effect on cue-elicited craving among alcoholics in treatment.Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving?
P2860
Q24244900-4F3A0D11-0C4A-4B44-9CAB-018D064F9C96Q24793186-6F292C5D-0E74-4041-8758-485550FDD55AQ30275691-316E2673-7E04-4632-8A2D-7FF9E2EDCECFQ30440516-FEC18F4A-48AA-4020-9322-A561BF739DCAQ33818913-13B2E2C5-28FA-46BB-9D61-CD219AADEC40Q34038943-76FFD39C-3CD6-4DE3-BD91-C20DBF2EEDDFQ34256516-D5850E64-D33B-4279-9D6C-623607977F1AQ34348078-256F6029-DD32-4EE2-8F45-B234E3ABDE6CQ34543952-B9DCD8DF-856F-490B-80C3-513C2601DAA2Q34689570-D062FA9C-2254-4993-9D75-9D1C8B4DD14AQ35589974-20E59A21-FBFA-4A6E-B642-70CE745F85FEQ35622645-174C0689-DA9F-450C-8551-60CA2C1AA579Q35892525-3A391001-B0BE-41E0-949C-B4AC733D06E0Q36223647-10448042-89CF-46D8-B7F6-25ACF122B32FQ36294656-5054734D-B44D-4CD8-A2A4-EC6F376D4F34Q36824245-B6C24118-10B7-4277-AED6-D700A2360B13Q37062538-ABACF1EF-75A1-4873-A222-9F70052B8132Q37179217-5B7079E5-1DB3-4BBC-981A-5F2117893B71Q37200944-A62ACE05-F5CB-4B01-AC35-F00AE356A53EQ37344738-C3C1A884-D41C-444F-8F98-33A154A9F8C3Q38139197-CDEEDF76-04FD-420B-88BC-7F3BFCD7C0F2Q38842262-40E8A499-A7A6-452A-A13B-3CDB1F2FC66EQ39162974-EF2F3F20-CEE9-49CF-A327-6C104441878DQ44374802-89CB2AC2-D754-42B3-95E2-6856D4C1D37AQ44493524-4B22A482-96EA-45F7-98C9-D6A38C84D947Q44666733-6394E028-2F1A-4D83-9287-669296D99890Q45222007-35854B67-EF60-4F60-B240-BD43BEF6350DQ48147795-6807D80B-0D7B-46B3-A0A9-00A8BD4A04CFQ51091561-ECEDE598-86D9-44B9-81F6-E7CC3F33F9D6Q51791744-B5C82984-2167-4D2A-A9E5-0914AD205F76Q51997591-AF5A6FD0-06AD-4AFC-BDC9-7BF89025E2DBQ52174765-5F46007A-160C-40B0-A221-5E7EEB234C75Q52177338-F1972882-A12B-4B4F-81F5-0E18981659A9Q52277469-83CD3FD9-FB5C-4557-AC44-7CBF671292BF
P2860
Naltrexone increases the latency to drink alcohol in social drinkers.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Naltrexone increases the latency to drink alcohol in social drinkers.
@en
Naltrexone increases the latency to drink alcohol in social drinkers.
@nl
type
label
Naltrexone increases the latency to drink alcohol in social drinkers.
@en
Naltrexone increases the latency to drink alcohol in social drinkers.
@nl
prefLabel
Naltrexone increases the latency to drink alcohol in social drinkers.
@en
Naltrexone increases the latency to drink alcohol in social drinkers.
@nl
P2093
P2860
P1476
Naltrexone increases the latency to drink alcohol in social drinkers.
@en
P2093
P2860
P304
P356
10.1111/J.1530-0277.1996.TB01679.X
P577
1996-06-01T00:00:00Z